DMSO might impact ligand binding, capsid stability, and RNA interaction in viral preparations

Sci Rep. 2024 Dec 6;14(1):30408. doi: 10.1038/s41598-024-81789-x.

Abstract

Dimethyl sulfoxide (DMSO) is a widely used solvent in drug research. However, recent studies indicate that even at low concentration DMSO might cause structural changes of proteins and RNA. The pyrazolopyrimidine antiviral OBR-5-340 dissolved in DMSO inhibits rhinovirus-B5 infection yet is inactive against RV-A89. This is consistent with our structural observation that OBR-5-340 is only visible at the pocket factor site in rhinovirus-B5 and not in RV-A89, where the hydrophobic pocket is collapsed. Here, we analyze the impact of DMSO in RV-A89 by high-resolution cryo-electron microscopy. Our 1.76 Å cryo-EM reconstruction of RV-A89 in plain buffer, without DMSO, reveals that the pocket-factor binding site is occupied by myristate and that the previously observed local heterogeneity at protein-RNA interfaces is absent. These findings suggest that DMSO elutes the pocket factor, leading to a collapse of the hydrophobic pocket of RV-A89. Consequently, the conformational heterogeneity observed at the RNA-protein interface in the presence of DMSO likely results from increased capsid flexibility due to the absence of the pocket factor and DMSO-induced affinity modifications. This local asymmetry may promote a directional release of the RNA genome during infection.

Keywords: DMSO; Dimethyl sulfoxide; HRV; Pocket factor; Rhinovirus.

MeSH terms

  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology
  • Binding Sites
  • Capsid Proteins / chemistry
  • Capsid Proteins / metabolism
  • Capsid* / chemistry
  • Capsid* / drug effects
  • Capsid* / metabolism
  • Cryoelectron Microscopy*
  • Dimethyl Sulfoxide* / chemistry
  • Dimethyl Sulfoxide* / pharmacology
  • Humans
  • Ligands
  • Protein Binding
  • RNA, Viral* / chemistry
  • RNA, Viral* / metabolism
  • Rhinovirus / drug effects

Substances

  • Dimethyl Sulfoxide
  • RNA, Viral
  • Ligands
  • Antiviral Agents
  • Capsid Proteins